Status:
RECRUITING
The Sarcoma Biology and Outcome Project
Lead Sponsor:
Prof. Dr. Richard F Schlenk
Conditions:
Sarcoma
Malignant Mesenchymoma
Eligibility:
All Genders
12+ years
Brief Summary
SarcBOP - An interdisciplinary and translational registry SarcBOP aims to establish a database that integrates every aspect possibly relevant to sarcoma treatment and research. SarcBOP thus will not ...
Detailed Description
The following data are collected and stored: * Demographics * Comorbidities * Clinical characteristics at diagnosis, relapse and progression * Radiologic images * Histological images * Treatments inc...
Eligibility Criteria
Inclusion
- Suspected or proven diagnosis of soft-tissue or bone sarcoma (STBS)
- Age ≥12 years
- Ability to understand nature and individual consequences of the registry
- Written informed consent
- Subjects who are physically or mentally capable of giving consent
Exclusion
- • Severe neurological or psychiatric disorder interfering with the ability to give written informed consent
Key Trial Info
Start Date :
July 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2032
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04758325
Start Date
July 23 2019
End Date
December 31 2032
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Center for Tumour Diseases, University Hospital Heidelberg
Heidelberg, Baden-Wurttemberg, Germany, 69120